Form 8-K - Current report:
SEC Accession No. 0001410939-21-000036
Filing Date
2021-08-04
Accepted
2021-08-04 06:41:22
Documents
14
Period of Report
2021-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20210804.htm   iXBRL 8-K 35708
2 EX-99.1 isee2qearningspressrelease.htm EX-99.1 81796
6 image_0.jpg GRAPHIC 14302
  Complete submission text file 0001410939-21-000036.txt   289894

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20210804.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20210804_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20210804_pre.xml EX-101.PRE 13063
7 EXTRACTED XBRL INSTANCE DOCUMENT isee-20210804_htm.xml XML 10952
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 211142256
SIC: 2834 Pharmaceutical Preparations